These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 11471193)

  • 1. Functional genomics of the Down syndrome.
    Nizetić D
    Croat Med J; 2001 Aug; 42(4):421-7. PubMed ID: 11471193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular mapping of Alzheimer-type dementia in Down's syndrome.
    Prasher VP; Farrer MJ; Kessling AM; Fisher EM; West RJ; Barber PC; Butler AC
    Ann Neurol; 1998 Mar; 43(3):380-3. PubMed ID: 9506555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The DYRK1A gene, encoded in chromosome 21 Down syndrome critical region, bridges between beta-amyloid production and tau phosphorylation in Alzheimer disease.
    Kimura R; Kamino K; Yamamoto M; Nuripa A; Kida T; Kazui H; Hashimoto R; Tanaka T; Kudo T; Yamagata H; Tabara Y; Miki T; Akatsu H; Kosaka K; Funakoshi E; Nishitomi K; Sakaguchi G; Kato A; Hattori H; Uema T; Takeda M
    Hum Mol Genet; 2007 Jan; 16(1):15-23. PubMed ID: 17135279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromosome 21 and down syndrome: from genomics to pathophysiology.
    Antonarakis SE; Lyle R; Dermitzakis ET; Reymond A; Deutsch S
    Nat Rev Genet; 2004 Oct; 5(10):725-38. PubMed ID: 15510164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene expression profiling in the adult Down syndrome brain.
    Lockstone HE; Harris LW; Swatton JE; Wayland MT; Holland AJ; Bahn S
    Genomics; 2007 Dec; 90(6):647-60. PubMed ID: 17950572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of phenotypic abnormalities of Down syndrome with an imbalance of genes on chromosome 21.
    Becker LE; Mito T; Takashima S; Onodera K; Friend WC
    APMIS Suppl; 1993; 40():57-70. PubMed ID: 8311992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 10 years of Genomics, chromosome 21, and Down syndrome.
    Antonarakis SE
    Genomics; 1998 Jul; 51(1):1-16. PubMed ID: 9693027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Determination of DNA sequence of the whole chromosome 21].
    Sakaki Y; Hattori M; Toyoda A; Watanabe H; Yada T; Taylor T; Park HS; Totoki Y; Fujiyama A
    Tanpakushitsu Kakusan Koso; 2000 Nov; 45(15):2520-7. PubMed ID: 11086412
    [No Abstract]   [Full Text] [Related]  

  • 9. Dosage-dependent over-expression of genes in the trisomic region of Ts1Cje mouse model for Down syndrome.
    Amano K; Sago H; Uchikawa C; Suzuki T; Kotliarova SE; Nukina N; Epstein CJ; Yamakawa K
    Hum Mol Genet; 2004 Jul; 13(13):1333-40. PubMed ID: 15138197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trisomy of chromosome 21 in leukemogenesis.
    Izraeli S; Rainis L; Hertzberg L; Smooha G; Birger Y
    Blood Cells Mol Dis; 2007; 39(2):156-9. PubMed ID: 17532652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene-dosage effect on chromosome 21 transcriptome in trisomy 21: implication in Down syndrome cognitive disorders.
    Kahlem P
    Behav Genet; 2006 May; 36(3):416-28. PubMed ID: 16557362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for dementia in people with down syndrome: issues in assessment and diagnosis.
    Bush A; Beail N
    Am J Ment Retard; 2004 Mar; 109(2):83-97. PubMed ID: 15000668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mental retardation in Down syndrome: from gene dosage imbalance to molecular and cellular mechanisms.
    Rachidi M; Lopes C
    Neurosci Res; 2007 Dec; 59(4):349-69. PubMed ID: 17897742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mental retardation and associated neurological dysfunctions in Down syndrome: a consequence of dysregulation in critical chromosome 21 genes and associated molecular pathways.
    Rachidi M; Lopes C
    Eur J Paediatr Neurol; 2008 May; 12(3):168-82. PubMed ID: 17933568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maternal balanced translocation (4;21) leading to an offspring with partial duplication of 4q and 21q without phenotypic manifestations of Down syndrome.
    El-Ruby M; Hemly NA; Zaki MS
    Genet Couns; 2007; 18(2):217-26. PubMed ID: 17710874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human chromosome 21/Down syndrome gene function and pathway database.
    Nikolaienko O; Nguyen C; Crinc LS; Cios KJ; Gardiner K
    Gene; 2005 Dec; 364():90-8. PubMed ID: 16310977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth and development of the brain in Down syndrome.
    Becker L; Mito T; Takashima S; Onodera K
    Prog Clin Biol Res; 1991; 373():133-52. PubMed ID: 1838182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyloid beta concentrations in older people with Down syndrome and dementia.
    Jones EL; Hanney M; Francis PT; Ballard CG
    Neurosci Lett; 2009 Feb; 451(2):162-4. PubMed ID: 19111900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic mechanisms involved in the phenotype of Down syndrome.
    Patterson D
    Ment Retard Dev Disabil Res Rev; 2007; 13(3):199-206. PubMed ID: 17910086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell array-based intracellular localization screening reveals novel functional features of human chromosome 21 proteins.
    Hu YH; Warnatz HJ; Vanhecke D; Wagner F; Fiebitz A; Thamm S; Kahlem P; Lehrach H; Yaspo ML; Janitz M
    BMC Genomics; 2006 Jun; 7():155. PubMed ID: 16780588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.